← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2013Last known activity
May 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06354816Lead sponsorPhase 4May 31, 2024
- NCT02487849Overall official - principal investigatorPhase 2Aug 1, 2017
- NCT02487849Lead sponsorPhase 2Aug 1, 2017
- NCT02492477Lead sponsorPhase 1Oct 1, 2015
- NCT01283763CollaboratorPhase 3May 1, 2013
Details
- Last known activity
- May 31, 2024